Skip to main content
Smart Investors Daily
bioMérieux S.A. logo

OTC · BMXXY

bioMérieux S.A.

Healthcare · Medical - Specialties

$9.46

Up+$0.53 (+5.94%)

Updated Oct 11, 2026, 1:02 PM

SID Score

4.7/10

Composite research score

Smart Money

46/100

Neutral

Market cap
14.67B
P/E ratio
33.93
Dividend yield
1.09%
52-week range
$7.12 – $14.55
Volume
739
Avg. volume
789

Price performance · BMXXY

BMXXY price history

1M range · 18 trading sessions · Daily adjusted prices

Prices through Oct 9, 2026

BMXXY closed at $9.46 after 18 trading sessions, up 13.29% for the selected period.

Last close
$9.46
Period change
+13.29%
Period low
$8.35
Period high
$9.53
Daily close
View OHLC price history
BMXXY OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 9, 2026$9.69$9.69$9.065$9.4598739
Oct 8, 2026$9.53$9.90$8.929$8.9293.08K
Oct 7, 2026$9.383$9.46$9.035$9.461.35K
Oct 6, 2026$9.30$9.30$8.97$8.971.36K
Oct 5, 2026$9.136$9.14$8.525$8.803.06K
Oct 2, 2026$9.041$9.041$9.041$9.041436
Oct 1, 2026$9.12$9.12$9.12$9.12331
Sep 30, 2026$9.25$9.25$9.24$9.24855
Sep 29, 2026$9.261$9.39$8.89$9.39791
Sep 28, 2026$9.51$9.53$9.455$9.531.59K
Sep 25, 2026$9.33$9.33$9.33$9.33529
Sep 24, 2026$9.165$9.25$8.835$9.252.34K
Sep 23, 2026$8.858$8.97$8.858$8.971.11K
Sep 22, 2026$8.597$8.85$8.375$8.851.37K
Sep 21, 2026$8.655$8.75$8.655$8.75824
Sep 18, 2026$8.67$8.67$8.67$8.67277
Sep 15, 2026$8.74$8.74$8.74$8.74133
Sep 14, 2026$8.709$8.709$8.35$8.35330

Latest BMXXY news

The latest Smart Investors Daily articles mentioning BMXXY.

BMXXY research

Overview

Company profile and research snapshot.

Company profile

BIOMERIEUX S A UNSP/ADR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
BMXXY recent ratings
DateFirmRatingTarget
Jul 30, 2026BNP PARIBASNeutral—
Jul 30, 2026ODDO BHFBuy—
Jul 29, 2026PIPER SANDLER COMPANIESNeutral—
Jul 10, 2026ODDO BHFBuy—
Jul 9, 2026ODDO BHFBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 8, 2026

bioMérieux (ENXTPA:BIM) Launches SPINCHIP, Is The Stock Fully Priced?

bioMérieux (ENXTPA:BIM) has put its new SPINCHIP point of care platform in front of emergency physicians in Paris, pairing the device with a CE marked high sensitivity cardiac troponin I test. Recent trading suggests investors are reacting positively to news like SPINCHIP, with the share price up 11.30% over 30 days and 12.70% over 90 days. However, the stock is still facing a year-to-date share price return that is down 26.26% and a 1-year total shareholder return that is down 27.11%,...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.